Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline <i>CDH1</i> mutation carriersRachel S. van der Post, Rebecca C. Fitzgerald, Ingrid P. Vogelaar et al.|Journal of Medical Genetics|2015Cited by 567
Hereditary diffuse gastric cancer: updated clinical practice guidelinesVanessa Blair, Tanis Godwin, Maybelle McLeod et al.|The Lancet Oncology|2020Cited by 493
Low risk of invasive lobular carcinoma of the breast in carriers of <i>BRCA1</i> (hereditary breast and ovarian cancer) and <i>TP53</i> (Li‐Fraumeni syndrome) germline mutationsYoan Ditchi, Patrick R. Benusiglio, Chloé Broudin et al.|The Breast Journal|2018Cited by 16
International Delphi consensus guidelines for follow-up after prophylactic total gastrectomy: the Life after Prophylactic Total Gastrectomy (LAP-TG) studyGeoffrey Roberts, Susan Parry, Patrick R. Benusiglio et al.|Gastric Cancer|2022Cited by 15
Deciphering dual clinical entities associated with <scp><i>TP53</i></scp> pathogenic variants: Insights from 53,085 <scp>HBOC</scp> panel analyses in French laboratoriesEdwige Kasper, Claude Houdayer, Flavie Boulouard et al.|International Journal of Cancer|2025Cited by 4